029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FUR631子宫内膜癌组织芯片，附病理分级、TNM和临床分期，63例/63点
点 数63例 数63
行 数7列 数9
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FUR631
 
子宫内膜癌组织微阵列芯片，包含60例子宫内膜样腺癌及3例正常组织，一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ute
-Uterus
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIC)
 
NAT (*)
 
Normal (*)
TISSUE  ARRAYS FUR631
1
2
3
4
5
6
7
8
9
A
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
B
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
C
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
D
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
E
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
F
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
G
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1135FUterusEndometrioid adenocarcinoma (sparse)1T2N0M0IIMalignant*N
A2257FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A3357FUterusEndometrioid adenocarcinoma (sparse)1T1bN0M0IBMalignant*N
A4438FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*N
A5549FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant5*5N
A6647FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant9*9N
A7756FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant3*2.5*1.2N
A8853FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant6*4*4N
A9954FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*2*0.5N
B11050FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant11*10*4N
B21137FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant6*4.5*3N
B31253FUterusEndometrioid adenocarcinoma (sparse)1T1aN0M0IAMalignant9*8*8N
B41368FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant7*4*4N
B51454FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant2*1.5*1N
B61543FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant8*7*6N
B71649FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*1N
B81750FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant4*2N
B91843FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2*2N
C11953FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant9*9*4N
C22037FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant4*3*1.5N
C32133FUterusEndometrioid adenocarcinoma1--2T1bN0M0IBMalignant11*9*4N
C42256FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3.5N
C52370FUterusEndometrioid adenocarcinoma2T1bN1M0IIICMalignant6*4*4N
C62452FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
C72546FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.5*2*0.8N
C82661FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant3*2N
C92770FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant9*3.5*2.5N
D12830FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
D22957FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
D33052FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D43158FUterusEndometrioid adenocarcinoma (sparse)2T1aN0M0IAMalignant*N
D53246FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D63374FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*3*2N
D73459FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant8*3*2.5N
D83554FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant2.5*2*1N
D93650FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*2N
E13770FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant1.5*4.5*2N
E23852FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2N
E33968FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant8*6*4N
E44054FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant9*5*3N
E54150FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant6*4*2.5N
E64258FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3*3N
E74343FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant7*3*3N
E84479FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4*3*0.8N
E94560FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*5*3N
F14663FUterusEndometrioid adenocarcinoma with necrosis2--3T3aN0M0IIIAMalignant9*3*2.5N
F24758FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant10*9*7N
F34849FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant5*5*4N
F44953FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant7*6*4N
F55060FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*3*2.5N
F65151FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant8*4.5*4.5N
F75251FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant4*3N
F85353FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant4*2.5*1.5N
F95462FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*1.2N
G15543FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant3.5*3*2.5N
G25666FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant*N
G35763FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
G45855FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*N
G55952FUterusEndometrioid adenocarcinoma3T2bN0M0IIBMalignant*N
G66062FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3*2*1N
G76152FUterusEndometrial tissue***NAT*N
G86246FUterusEndometrial tissue***NAT*N
G96354FUterusEndometrial tissue***Normal*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情